Japan Breast Cancer Research Group
Clinical trials sponsored by Japan Breast Cancer Research Group, explained in plain language.
-
Can a drug work a second time? trial tests retreatment for tough breast cancers
Disease control CompletedThis study tested whether restarting a drug called pertuzumab, along with standard treatments, could help control advanced HER2-positive breast cancer that had previously been treated with it. It involved 226 women with advanced breast cancer. The goal was to see if this retreatm…
Phase: PHASE3 • Sponsor: Japan Breast Cancer Research Group • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New combo therapy aims to control advanced breast cancer with fewer side effects
Disease control CompletedThis completed Phase 3 trial tested whether a new drug combination (eribulin + pertuzumab + trastuzumab) could control advanced HER2-positive breast cancer as well as the standard treatment (taxane + pertuzumab + trastuzumab), but with better quality of life. It involved 446 wome…
Phase: PHASE3 • Sponsor: Japan Breast Cancer Research Group • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC